Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20152016201720182019
Sales11,84,431,632,851,30
EBITDA-42,9-72,4-120-132-149
Operating profit (EBIT)-43,6-73,9-120-130-144
Pre-Tax Profit (EBT)-56,3-83,2-124-130-148
Net income-39,4-48,9-97,2-101-113
P/E ratio-11,4-6,93-4,06-4,01-3,45
EPS ( $ )-0,21-0,21-0,40-0,41-0,47
Dividend per Share ( $ )-----
Yield-----
Reference price ( $ )2.4021.4551.622191.622191.62219
Announcement Date04/07/2016
09:05am
04/06/2017
06:33am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt------
Finance-31027517111018,5
Operating income (EBITDA)--42,9-72,4-120-132-149
Leverage
(Debt/EBITDA)
------
Capital Expenditure-3,463,683,003,754,40
Book Value Per Share (BVPS)--0,76 $-6,00 $-2,30 $-57,8 $
Cash Flow per Share--0,15 $---0,55 $-
Announcement Date01/01/1970
01:00am
04/07/2016
09:05am
04/06/2017
06:33am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 383 M$ -
Entreprise Value (EV) 212 M$ 273 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS)
Capitalization / Revenue 235x 134x
EV / Revenue 130x 95,8x
EV / EBITDA -1,76x -2,06x
Yield (DPS / Price) - -
Price to book (Price / BVPS) -0,27x -0,71x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) -7 354% -4 547%
operating Leverage (Delta EBIT / Delta Sales) -0,97x -
Net Margin (Net Profit / Revenue) -5 982% -3 526%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   185% 132%
Cash Flow / Sales - -4 582%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 1,42x 0,83x
EPS & Dividend